Injection Drug Use-Related Infective Endocarditis Affecting More Young, White Patients — Physician’s First Watch
Injection Drug Use-Related Infective Endocarditis Affecting More Young, White Patients
By Amy Orciari Herman
Infective endocarditis related to injection drug use is affecting more and more white, young, female adults, according to a study in Open Forum Infectious Diseases.
Using a U.S. inpatient database, researchers identified over 16,000 hospitalizations for infective endocarditis from 2000 to 2013. The proportion related to injection drug use increased from 7–8% to 12% over this period.
Young people (aged 15–34) accounted for an increasing proportion of injection drug use-related infective endocarditis, with a sharp increase from 2008 to 2013 (from 28% to 42%). In addition, whites accounted for just 40% of cases in 2000, increasing to 69% in 2013. Overall, injection drug use-related infective endocarditis was less common among women than men, except among young people, where women accounted for 53% of cases.
The authors say their results "demonstrate that trends in [injection drug use-related infective endocarditis] appear to mirror those of the intertwined prescription opioid, heroin, [hepatitis C], and overdose epidemics throughout the country."